Mölndal, Sweden

Hongming Chen


 

Average Co-Inventor Count = 11.0

ph-index = 1

Forward Citations = 1(Granted Patents)


Company Filing History:


Years Active: 2020-2021

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Inventor Spotlight: Hongming Chen

Introduction: Hongming Chen is an innovative inventor based in Mölndal, Sweden, known for his contributions to pharmaceutical science. With a focus on developing novel compounds for therapeutic applications, he holds two patents that demonstrate his commitment to addressing significant health challenges.

Latest Patents: Hongming Chen's latest patents include groundbreaking work on inhibitors of protease-activated receptor-2. The first patent discusses substituted imidazole compounds, along with pharmaceutical compositions containing these compounds. These methods aim to treat various conditions such as pain, musculoskeletal inflammation, neuroinflammatory disorders, airway inflammation, itch, dermatitis, colitis, and other related issues. His second patent similarly involves substituted imidazole and triazole compounds with a focus on the same therapeutic applications. The chemical compounds are characterized by a specific formula where X is N or CH, Z and Y are N or C (with specific restrictions), and further defined substituents as described in the patent.

Career Highlights: Hongming Chen is currently employed at Heptares Therapeutics Limited, where he applies his expertise in medicinal chemistry to develop innovative treatments. His work focuses on identifying and optimizing new therapeutic compounds that target important pathways in various diseases.

Collaborations: Throughout his career, Hongming has collaborated with notable professionals in the field, including John Graham Cumming and Frank Xinhe Wu. These collaborations have contributed to the depth of research and development within his projects, advancing the pursuit of effective medical solutions.

Conclusion: Hongming Chen stands out as a significant contributor to pharmaceutical innovation, with his patents reflecting a dedication to improving healthcare outcomes. With his expertise and collaborative efforts, he continues to make strides in the development of novel therapies targeting complex medical conditions.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…